Evaluation the Efficacy of Ganagliflozin Proline Tablets in Type 2 Diabetes Mellitus Patients with Mild Cognitive Impairment: A Randomized, Open-label Parallel study (GLOW-MCI)

Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2025
This article has no abstract
Epistemonikos ID: 455b96bc5da89bda2dd448b6d4e889777e0a8b22
First added on: Apr 24, 2026